Quick Answer
UTAH MEDICAL PRODUCTS INC reported Operating Income Loss of $11.40 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -16.1% in Operating Income Loss from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $2.16 million | Q2 2011: $3.23 million | Q3 2011: $3.54 million | Q1 2012: $4.12 million | Q2 2012: $3.55 million | Q3 2012: $3.96 million | Q1 2013: $3.89 million | Q2 2013: $3.72 million | Q3 2013: $3.67 million | Q1 2014: $3.84 million | Q2 2014: $4.06 million | Q3 2014: $4.00 million | Q1 2015: $3.88 million | Q2 2015: $3.97 million | Q3 2015: $4.00 million | Q1 2016: $4.31 million | Q2 2016: $4.32 million | Q3 2016: $3.94 million | Q1 2017: $4.73 million | Q2 2017: $5.03 million | Q3 2017: $4.68 million | Q1 2018: $4.97 million | Q2 2018: $5.06 million | Q3 2018: $4.40 million | Q1 2019: $4.10 million | Q2 2019: $4.48 million | Q3 2019: $4.37 million | Q1 2020: $3.86 million | Q2 2020: $1.98 million | Q3 2020: $3.59 million | Q1 2021: $3.89 million | Q2 2021: $4.77 million | Q3 2021: $5.10 million | Q1 2022: $4.52 million | Q2 2022: $5.06 million | Q3 2022: $5.14 million | Q1 2023: $4.44 million | Q2 2023: $4.43 million | Q3 2023: $3.97 million | Q1 2024: $3.88 million | Q2 2024: $3.44 million | Q3 2024: $3.34 million | Q1 2025: $3.15 million | Q2 2025: $3.20 million | Q3 2025: $2.61 million.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Operating Income Loss has grown by 20.9%.
- Historical annual values: Fiscal year 2025: $11.40 million | Fiscal year 2024: $13.59 million | Fiscal year 2023: $16.78 million | Fiscal year 2022: $19.79 million | Fiscal year 2021: $18.88 million | Fiscal year 2020: $13.71 million | Fiscal year 2019: $17.63 million | Fiscal year 2018: $18.70 million | Fiscal year 2017: $19.01 million | Fiscal year 2016: $16.19 million | Fiscal year 2015: $15.65 million | Fiscal year 2014: $16.20 million | Fiscal year 2013: $14.83 million | Fiscal year 2012: $15.20 million | Fiscal year 2011: $11.84 million | Fiscal year 2010: $8.92 million | Fiscal year 2009: $9.43 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: